Patent details

Basic Information

Publication number:

LUC00378

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP197518079

Legal Status:

Pending & Published

Application number:

LUC00378

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/24/1846

Marketing Authorization Type:

Marketing Authorization Date:

23/08/2024

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

11/02/2025

First Marketing Authorization date:

23/08/2024

Grant date:

Activation date:

Publication date:

12/02/2025

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

23/08/2039

SPC Extension Expiration:

23/08/2039

Rejection date:

Withdrawal date:

Owner

From:

11/02/2025

 

 

Name:

AEGIS THERAPEUTICS, LLC

Address:

3430 Carmel Mountain Road Suite 300, CA 92121, San Diego, United States (US)

Name:

ARS PHARMACEUTICALS OPERATIONS, INC.

Address:

11682 El Camino Real Suite 120, CA 92130, San Diego, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

11/02/2025

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Publication

Bulletin

Bulletin Heading:

SPC1

Bulletin edition number:

2025/04

Publication date:

04/03/2025

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

Annual Fees

Annual Fee Due Date:

28/02/2039

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
12/02/2025	Outgoing Correspondence	1
11/02/2025	Application Form	3
11/02/2025	Marketing authorization	3
11/02/2025	MA publication	11
11/02/2025	Summary of the product caracteristics	37
11/02/2025	General Document	13
11/02/2025	General Document	2